Novel Three-Dimensional Organotypic Liver Bioreactor to Directly Visualize Early Events in Metastatic Progression

Advances in Cancer Research

Volumn 97, Issue , 2007, Pages 225-246

  Yates, Clayton ^a   Shepard, Chistopher R ^a   Papworth, Glenn ^b   Dash, Ajit ^c   Beer Stolz, Donna ^a,b   Tannenbaum, Steven ^c   Griffith, Linda ^c   Wells, Alan ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; RED FLUORESCENT PROTEIN;

BIOREACTOR; BREAST CARCINOMA; CANCER GROWTH; CANCER INVASION; CELL ULTRASTRUCTURE; EX VIVO STUDY; FLUID FLOW; FLUORESCENCE MICROSCOPY; HUMAN; LIVER; LIVER PARENCHYMA; METASTASIS; NECROSIS; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROSTATE CARCINOMA; REVIEW; SCALE UP; TRANSITIONAL CELL CARCINOMA; TUMOR CELL; TUMOR GROWTH; TUMOR LOCALIZATION;

ANIMALS; BIOREACTORS; BREAST NEOPLASMS; CARCINOMA; CELL LINE, TUMOR; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; EQUIPMENT DESIGN; FEMALE; GREEN FLUORESCENT PROTEINS; HEPATOCYTES; HUMANS; LIVER CIRCULATION; LIVER NEOPLASMS; MALE; MICROSCOPY, FLUORESCENCE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; ORGAN CULTURE TECHNIQUES; PERFUSION; PROSTATIC NEOPLASMS; RATS; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC; STROMAL CELLS;

EID: 34047159398     PISSN: 0065230X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-230X(06)97010-9     Document Type: Review

References (75)

1. Assoian R. Anchorage-dependent cell cycle progression. J. Cell Biol. 136 (1997) 1-4
2. Atula S., Grenman R., and Syrjanen S. Fibroblasts can modulate the phenotype of malignant epithelial cells in vitro. Exp. Cell Res. 235 (1997) 180-187
3. Barron V., Lyons E., Stenson-Cox C., McHugh P.E., and Pandit A. Bioreactors for cardiovascular cell and tissue growth: A review. Ann. Biomed. Eng. 31 (2003) 1017-1030
4. Bauwens C., Yin T., Dang S., Peerani R., and Zandstra P.W. Development of a perfusion fed bioreactor for embryonic stem cell-derived cardiomyocyte generation: Oxygen-mediated enhancement of cardiomyocyte output. Biotechnol. Bioeng. 90 (2005) 452-461
5. Bhowmick N.A., and Moses H.L. Tumor-stroma interactions. Curr. Opin. Genet. Dev. 15 (2005) 97-101
6. Bhowmick N.A., Chytil A., Plieth D., Gorska A.E., Dumont N., Shappell S., Washington M.K., Neilson E.G., and Moses H.L. TGF-β signaling in fibroblasts modulate the oncogenic potential of adjacent epithelia. Science 303 (2004) 848-851
7. Braccini A., Wendt D., Jaquiery C., Jakob M., Heberer M., Kenins L., Wodnar-Filipowicz A., Quarto R., and Martin I. Three-dimensional perfusion culture of human bone marrow cells and generation of osteoinductive grafts. Stem Cells 23 (2005) 1066-1072
8. Brown L.A., Arterburn L.M., Miller A.P., Cowger N.L., Hartley S.M., Andrews A., Silber P.M., and Li A.P. Maintenance of liver functions in rat hepatocytes cultured as spheroids in a rotating wall vessel. In vitro Cell. Dev. Biol. Anim. 39 (2003) 13-20
9. Cartmell S.H., Porter B.D., Garcia A.J., and Guldberg R.E. Effects of medium perfusion rate on cell-seeded three-dimensional bone constructs in vitro. Tissue Eng. 9 (2003) 1197-1203
10. Chambers A.F., MacDonald I.C., Schmidt E.E., Koop S., Morris V.L., Khokha R., and Groom A.C. Steps in tumor metastasis: New concepts from intravital videomicroscopy. Cancer Metastasis Rev. 14 (1995) 279-301
11. Condeelis J., Singer R., and Segall J.E. The great escape: When cancer cells hijack the genes for chemotaxis and motility. Ann Rev. Cell Dev. Biol. 21 (2005) 697-718
12. Condeelis J.S., Wyckoff J.B., Bailly M., Pestell R., Lawrence D., Backer J., and Segall J.E. Lamellipodia in invasion. Semin. Cancer Biol. 11 (2001) 119-128
13. Cristofanilli M., Budd G.T., Ellis M.J., Stopeck A., Matera J., Miller M.C., Reuben J.M., Doyle G.V., Allard W.J., Terstappen L.W., and Hayes D.F. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N. Engl. J. Med. 351 (2004) 781-791
14. Donovan D., Brown N.J., Bishop E.T., and Lewis C.E. Comparison of three in vitro human "angiogenesis" assays with capillaries formed in vivo. Angiogenesis 4 (2001) 113-121
15. Ewing C.M., Ru N., Morton R.A., Robinson J.C., Whellock M.J., Johnson K.R., Barrett J.C., and Isaacs W.B. Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: Correlation with re-expression of a-catenin and restoration of E-cadherin function. Cancer Res. 55 (1995) 4813-4817
16. Ewing J. "Neoplastic Diseases," (1922), WB Saunders Company, Philadelphia, London 784-785
17. Fidler I.J. The pathogenesis of cancer metastasis: "The seed and soil" hypothesis revisited. Nat. Rev. Cancer 3 (2003) 453-458
18. Fiegel H.C., Havers J., Kneser U., Smith M.K., Moeller T., Kluth D., Mooney D.J., Rogiers X., and Kaufmann P.M. Influence of flow conditions and matrix coatings on growth and differentiation of three-dimensionally cultured rat hepatocytes. Tissue Eng. 10 (2004) 165-174
19. Franko A.J., and Koch C.J. The radiation response of hypoxic cells in EMT6 spheroids in suspension culture does model data from EMT6 tumors. Radiat. Res. 96 (1983) 497-504
20. Gerlach J.C., Schnoy N., Encke J., Smith M.D., Muller C., and Neuhaus P. Improved hepatocyte in vitro maintenance in a culture model with woven multicompartment capillary systems: Electron microscopy studies. Hepatology 22 (1995) 546-552
21. Ghiso J.A.A., Kovalski K., and Ossowski L. Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling. J. Cell Biol. 147 (1999) 89-103
22. Gleave M.E., Hsieh J.T., vonEschenbach A.C., and Chung L.W.K. Prostate and bone fibroblasts induce human prostate cancer growth in vivo: Implications for bidirectional tumor-stromal cell interaction in prostate carcinoma growth and metastasis. J. Urol. 147 (1992) 1151-1159
23. Goswami S., Sahai E., Wyckoff J.B., Cammer M., Cox D., Pixley F.J., Stanley E.R., Segall J.E., and Condeelis J.S. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res. 65 (2005) 5278-5283
24. Graff J.R., Gabrielson E., Fujii H., Baylin S.B., and Herman J.G. Methylation patterns of the E-cadherin 5′XπΓ island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J. Biol. Chem. 275 (2000) 2727-2732
25. Griffith L.G., and Swartz M.A. Capturing complex 3D tissue physiology in vitro. Nat. Rev. Mol. Cell. Biol. 7 (2006) 211-224
26. Griffith L.G., Wu B., Cima M.J., Powers M.J., Chaignaud B., and Vacanti J.P. In vitro organogenesis of liver tissue. Ann. NY Acad. Sci. 831 (1997) 382-397
27. Grunert S., Jechlinger M., and Beug H. Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat. Rev. Mol. Cell. Biol. 4 (2003) 657-665
28. Helm C.E., Fleury M.E., Zisch A.H., Boschetti F., and Swartz M.A. Synergy between interstitial flow and VEGF directs capillary morphogenesis in vitro through a gradient amplification mechanism. Proc. Natl. Acad. Sci. USA 44 (2005) 15779-15784
29. Jasmund I., and Bader A. Bioreactor developments for tissue engineering applications by the example of the bioartificial liver. Adv. Biochem. Eng. Biotechnol. 74 (2002) 99-109
30. Jones P.A., and Baylin S.B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3 (2002) 415-428
31. Kaihara S., Kim S., Kim B.S., Mooney D.J., Tanaka K., and Vacanti J.P. Survival and function of rat hepatocytes cocultured with nonparenchymal cells or sinusoidal endothelial cells on biodegradable polymers under flow conditions. J. Pediatr. Surg. 35 (2000) 1287-1290
32. Kaplan R.N., Riba R.D., Zacharoulis S., Bramley A.H., Vincent L., Costa C., MacDonald D.D., Jin D.K., Shido K., Kerns S.A., Zhu Z., Hicklin D., et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438 (2005) 820-827
33. Kassis J., Moellinger J., Lo H., Greenberg N., Kim H.-G., and Wells A. A role for phospholipase C-γ-mediated signaling in tumor cell invasion. Clin. Cancer Res. 5 (1999) 2251-2260
34. Kassis J., Lauffenburger D.A., Turner T., and Wells A. Tumor invasion as dysregulated cell motility. Semin. Cancer Biol. 11 (2001) 105-118
35. Kassis J., Radinsky R., and Wells A. Motility is rate-limiting for invasion of bladder carcinoma cell lines. Int. J. Biochem. Cell Biol. 34 (2002) 262-275
36. Kim H., Turner T., Kassis J., Souto J., and Wells A. EGF receptor signaling in prostate development. Histol. Histopathol. 14 (1999) 1175-1182
37. Kowalski P.J., Rubin M.A., and Kleer C.G. E-cadherin expression in primary carcinoma of the breast and its distant metastases. Breast Cancer Res. 5 (2003) R217-R222
38. Kunz-Schughart L.A. Multicellular tumor spheroids: Intermediates between monolayer culture and in vivo tumor. Cell Biol. Int. 23 (1999) 157-161
39. Landman K.A., and Please C.P. Tumour dynamics and necrosis: Surface tension and stability. Math. Med. Biol. 18 (2001) 131-158
40. Luzzi K.J., MacDonald I.C., Schmidt E.E., Kerkvliet N., Morris V.L., Chambers A.F., and Groom A.C. Multistep nature of metastatic inefficiency: Dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am. J. Pathol. 153 (1998) 865-873
41. Mamoune A., Luo J.-H., Lauffenburger D.A., and Wells A. m-Calpain as a target for limiting prostate cancer invasion. Cancer Res. 63 (2003) 4632-4640
42. Mamoune A., Kassis J., Kharait S., Kloeker S., Manos E., Jones D.A., and Wells A. DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling. Exp. Cell Res. 299 (2004) 91-100
43. Margolis L., Hatfill S., Chuaqui R., Vocke C., Emmert-Buck M., Linehan W.M., and Duray P.H. Long term organ culture of human prostate tissue in a NASA-designed rotating wall bioreactor. J. Urol. 161 (1999) 290-297
44. Martin I., Wendt D., and Heberer M. The role of bioreactors in tissue engineering. Trends Biotechnol. 22 (2004) 80-86
45. Michalopoulos G.K., Bowen W.C., Zajac V.F., Beer-Stolz D., Watkins S., Kostrubsky V., and Strom S. Morphogenetic events in mixed cultures of rat hepatocytes and non-parenchymal cells maintained in biological matrices in the presence of hepatocyte growth factor and epidermal growth factor. Hepatology 29 (1999) 90-100
46. Minn A.J., Gupta G.P., Siegel P.M., Bos P.D., Shu W., Girl D.D., Viale A., Olshen A.B., Gerald W.L., and Massague J. Genes that mediate breast cancer metastasis to lung. Nature 436 (2005) 518-524
47. Navarro F.A., Mizuno S., Huertas J.C., Glowacki J., and Orgill D.P. Perfusion of medium improves growth of human oral neomucosal tissue constructs. Wound Repair Regen. 9 (2001) 507-512
48. Nelson C.M., and Bissell M.J. Modeling dynamic reciprocity: Engineering three-dimensional culture models of breast architecture, function, and neoplastic transformation. Semin. Cancer Biol. 15 (2005) 342-352
49. Paget S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev. 8 (1989) 98-101
50. Powers M.J., and Griffith L.G. Adhesion-guided in vitro morphogenesis in pure and mixed cultures. Microsc. Res. Tech. 43 (1998) 379-384
51. Powers M.J., Domansky K., Capitano A., Kalezi A., Udapadhaya A., Kaazempur-Mofrad M.R., Kurzawski P., Wack K.E., Stolz D.B., Kamm R., and Griffith L.G. A microarray perfusion bioreactor for 3D liver culture. Biotechnol. Bioeng. 78 (2002) 257-269
52. Powers M.J., Janigian J., Wack K.E., Baker C., Stolz D.B., and Griffith L.G. Functional behavior of primary rat liver cells in a 3D perfused microarray bioreactor. Tissue Eng. 8 (2002) 499-513
53. Proia D.A., and Kuperwasser C. Stroma: Tumor agonist or antagonist. Cell Cycle 4 (2005) 1022-1025
54. Rhiel M.H., Cohen M.B., Arnold M.A., and Murhammer D.W. On-line monitoring of human prostate cancer cells in a perfusion rotating wall vessel by near-infrared spectroscopy. Biotechnol. Bioeng. 86 (2004) 852-861
55. Salven P., Mustjoki S., Alitalo R., Alitalo K., and Rafii S. VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells. Blood 101 (2003) 168-172
56. Santini M.T., and Rainaldi G. Three-dimensional spheroid model in tumor biology. Pathobiology 67 (1999) 148-157
57. Schmeichel K.L., and Bissell M.J. Modeling tissue-specific signaling and organ function in three dimensions. J. Cell Sci. 116 (2003) 2377-2388
58. Semino C.E., Kamm R.D., and Lauffenburger D.A. Autocrine EGF receptor activation mediates endothelial cell migration and vascular morphogenesis induced by VEGF under interstitial flow. Exp. Cell Res. 312 (2006) 289-298
59. Shah R.B., Mehra R., Chinnaiyan A.M., Shen R., Ghosh D., Zhou M., MacVicar G.R., Varambally S., Harwood J., Bismar T.A., Kim R., Rubin M.A., et al. Androgen-independent prostate cancer is a heterogeneous group of diseases. Cancer Res. 64 (2004) 9209-9216
60. Sivaraman A., Iida T., Leach J.K., Townsend S., Hogan B.J., Fry R., Samson L., Tannenbaum S.R., and Griffith L.G. A microscale in vitro physiological modle of the liver: Preditive screens for drug metabolism and enzyme induction. Curr. Drug Metab. 6 (2005) 569-592
61. Tarin D. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res. 65 (2005) 5996-6000
62. Thompson E.W., and Newgreen D.F. Carcinoma invasion and metastasis: A role for epithelial-mesenchymal transition. Cancer Res. 65 (2005) 5991-5995
63. Timmers M., Vekemans K., Vermijlen D., Asosingh K., Kuppen P., Bouwens L., Wisse E., and Braet F. Interactions between rat colon carcinoma cells and kupffer cells during the onset of hepatic metastasis. Int. J. Cancer 112 (2004) 793-802
64. Timmins N.E., Dietmair S., and Nielsen L.K. Hanging-drop multicellular spheroids as a model of tumour angiogenesis. Angiogenesis 7 (2004) 97-103
65. Tlsty T.D. Stromal cells can contribute oncogenic signals. Semin. Cancer Biol. 11 (2001) 97-104
66. Torisawa Y.S., Shiku H., Yasukawa T., Nishizawa M., and Matsue T. Multi-channel 3-D cell culture device integrated on a silicon chip for anticancer drug sensitivity test. Biomaterials 26 (2005) 2165-2172
67. Tsai K.K., Chuang E.Y., Little J.B., and Yuan Z.M. Cellular mechanisms for low-dose ionizing radiation-induced perturbation of the breast tissue microenvironment. Cancer Res. 65 (2005) 6734-6744
68. Turner T., Chen P., Goodly L.J., and Wells A. EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells. Clin. Exp. Metastasis 14 (1996) 409-418
69. Turner T., VanEpps-Fung M., Kassis J., and Wells A. Molecular inhibition of PLCγ signaling abrogates DU-145 prostate tumor cell invasion. Clin. Cancer Res. 3 (1997) 2275-2282
70. Wang W., Goswami S., Sahai E., Wyckoff J.B., Segall J.E., and Condeelis J.S. Tumor cells caught in the act of invading: Their strategy for enhanced cell motility. Trends Cell Biol. 15 (2005) 138-145
71. Wells A. Tumor invasion: Role of growth factor-induced cell motility. Adv. Cancer Res. 78 (2000) 31-101
72. Wyckoff J., Wang W., Lin E.Y., Wang Y., Pixley F., Stanley E.R., Graf T., Pollard J.W., Segall J., and Condeelis J. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res. 64 (2004) 7022-7029
73. Xie H., Turner T., Wang M.-H., Singh R.K., Siegal G.P., and Wells A. In vitro invasiveness of DU-145 human prostate carcinoma cells is modulated by EGF receptor-mediated signals. Clin. Exp. Metastasis 13 (1995) 407-419
74. Yates C., Wells A., and Turner T. Luteinizing hormone releasing hormone (LHRH) analog reverses the cell adhesion profile of DU-145 human prostate carcinoma. Br. J. Cancer 92 (2005) 366-375
75. Zhao F., Pathi P., Grayson W., Xing Q., Locke B.R., and Ma T. Effects of oxygen transport on 3-d human mesenchymal stem cell metabolic activity in perfusion and static cultures: Experiments and mathematical model. Biotechnol. Progress 21 (2005) 1269-1280